Studies Implemented by University of North Carolina Lilongwe CRS
| Study Number | Study Title | Study Status | Study Restriction |
|---|---|---|---|
|
(11954) |
Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission: A Phase I/II Proof of Concept Study |
Enrolling |
US & Non-US |
|
(11878) |
Longitudinal Developmental and Neuropsychological Assessments of HIV-Infected Participants of P1060 and HIV-Uninfected Controls |
Closed to Follow Up |
Non-US |
|
(11689) |
Phase IV Evaluation of the Steady State Pharmacokinetics of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1 Infected Children |
Closed to Follow Up |
Non-US |
|
(10790) |
Maternal and Infant Monitoring for Evidence of Toxicity Related to Tenofovir Exposure: The Bone and Kidney Health Substudy of PROMISE Protocol: Promoting Maternal and Infant Survival Everywhere |
Closed to Follow Up |
Non-US |
|
(10765) |
Pharmacology of Artemisinin-Based Antimalarial Therapy Within the Context of Antiretroviral Therapy |
Participants Off Study and Primary Analysis Completed |
Non-US |
|
(10661) |
P1060 Substudy Comparing Differences in Malaria Parasitemia by Real-Time Quantitative PCR in HIV-Infected Infants and Children on PI-Based HAART Versus NNRTI-Based HAART |
Concluded |
US & Non-US |
|
(10166) |
Phase II, Parallel, Randomized Clinical Trials Comparing the Responses to Initiation of NNRTI-Based Versus PI-Based Antiretroviral Therapy in HIV-Infected Infants Who Have and Have Not Previously Received Single-Dose Nevirapine for Prevention of Mother-to-Child HIV Transmission |
Participants Off Study and Primary Analysis Completed |
Non-US |
|
(38506) |
Evaluating a Group-Based Intervention to Improve Mental Health and ART Adherence in Adolescents Living with HIV in Low Resource Settings |
Pending |
Non-US |
|
(30129) |
Phase III Study of the Virologic Efficacy and Safety of Dolutegravir-Containing versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and their Infants |
Closed to Accrual |
US & Non-US |
|
(20735) |
Phase I/II Multisite, Randomized, Controlled Study of Monoclonal Antibody VRC01 with Combination Antiretroviral Therapy to Promote Clearance of HIV-1-Infected Cells in Infants |
Enrolling |
US & Non-US |
|
(12026) |
A Phase I/II Trial of the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and Isoniazid in HIV-1-infected and HIV-1-uninfected Pregnant and Postpartum Women with Latent Tuberculosis Infection |
Closed to Accrual |
US & Non-US |
|
(10777) |
Breastfeeding Version of the PROMISE Study: Promoting Maternal and Infant Survival Everywhere |
Closed to Follow Up |
Non-US |